Liminatus Pharma, Inc. · NASDAQ:LIMN
Mitchell P. Kopin's stake in Liminatus Pharma, Inc. fell to 4.99% (Schedule 13G)
Event Feb 17, 2026 · Filed Feb 20, 2026
Mitchell P. Kopin's stake in Liminatus Pharma, Inc. fell to 4.99%, 2,065,885 shares, as a passive investor on Feb 17, 2026. Filed Feb 20, 2026 (Schedule 13G).
- Stake
- 4.99%
- Shares
- 2,065,885
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Mitchell P. Kopin | 4.99% | 2,065,885 |
| Daniel B. Asher | 4.99% | 2,065,885 |
| Intracoastal Capital LLC | 4.99% | 2,065,885 |
Source
Related
- Liminatus Pharma, Inc.
- Mitchell P. Kopin
- Liminatus Pharma, Inc. shareholders
- Schedule 13G · Samda Biolab Co., Ltd. · Jul 22, 2026
- Form 4 · Valetudo Therapeutics LLC · Jul 14, 2026
- Schedule 13D/A · Valetudo Therapeutics LLC · Jul 14, 2026
- Form 4 · Valetudo Therapeutics LLC · Jul 6, 2026
- Schedule 13G/A · Ewon Comfortech Co., Ltd. · Jul 6, 2026